LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...

The posters cover the Company’s new payload class, the ProAlk series, its CA242-directed ADC, IKS04, being developed for the treatment of gastrointestinal (GI) cancers, and its proprietary ...

Due to antitrust concerns raised by the Portuguese Competition Authority (AdC), the targeted advertising platform Playce will be suspended from May 1st. This platform – used by major telecom operators ...

作为实体瘤治疗领域的新兴靶点，CDH17正以双抗、三抗、ADC等多赛道并行的姿态掀起研发浪潮。 日前，美国癌症研究协会（AACR）公布了2025年会研究 ...

The Japanese pharmaceutical company Taiho Pharmaceutical is set to acquire the Swiss antibody-drug conjugate (ADC) company Araris Biotech for $400 million. Taiho and Araris have been collaborating ...

The findings were presented at the 15 th World ADC London 2025, taking place from March 3 to 6 at Novotel London West, London, UK. “We are excited to share groundbreaking data on SOT109 ...

Paclitaxel, ifosfamide, cisplatin (TIP) in patients with advanced urethral adenocarcinoma: A single center, retrospective analysis. Adjuvant nivolumab (NIVO) vs placebo (PBO) for high-risk ...

BR111 is an antibody-drug conjugate (ADC) targeting dual epitopes of ROR1, intended for the treatment of ROR1-positive hematological malignancies and solid tumors. ROR1 is a transmembrane receptor ...

The ADC 104th Annual Awards, the world’s longest continuously running awards program celebrating design and craft excellence, has launched its call for entries alongside a striking new campaign ...

ADC是肿瘤领域发展最快的治疗方式之一，目前已有15种ADC获批，超过210种正在进行临床试验。近年来，ADC的药物研发进入百花齐放阶段，特别是在HER2 ...

ADC药物研发的高景气，也促进了CRO/CDMO需求的快速增长，相关外包服务市场持续繁荣。 近年来，抗体偶联药物（ADC）技术加速 ...